A case of lung adenocarcinoma with a novel CD74 ‐ ROS1 fusion variant identified by comprehensive genomic profiling that responded to crizotinib and entrectinib-Reference-Cited by-同舟云学术

A case of lung adenocarcinoma with a novel CD74 ‐ ROS1 fusion variant identified by comprehensive genomic profiling that responded to crizotinib and entrectinib

Published:2021-07-28 Issue:18 Volume:12 Page:2504-2507
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Hashiguchi Mizuha Haraguchi¹^ORCID,Sato Takashi¹²³^ORCID,Watanabe Rinako¹,Kagyo Junko¹,Matsuzaki Tomohiko⁴,Domoto Hideharu⁵,Kato Terufumi⁶,Nakahara Yoshiro²⁶,Yokose Tomoyuki⁷,Hiroshima Yukihiko⁸,Shiomi Tetsuya¹

Affiliation:

1. Division of Pulmonary Medicine, Department of Medicine Keiyu Hospital Yokohama Japan

2. Department of Respiratory Medicine Kitasato University School of Medicine Sagamihara Japan

3. Division of Pulmonary Medicine, Department of Medicine Keio University School of Medicine Tokyo Japan

4. Department of Surgery Keiyu Hospital Yokohama Japan

5. Department of Pathology Keiyu Hospital Yokohama Japan

6. Division of Pulmonary Medicine Kanagawa Cancer Center Yokohama Japan

7. Division of Pathology Kanagawa Cancer Center Yokohama Japan

8. Center for Cancer Genome Medicine Kanagawa Cancer Center Yokohama Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14093

Reference20 articles.

1. ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers

2. A catalog of 5′ fusion partners in ROS1‐positive NSCLC circa 2020;Ou SI;JTO Clin Res Rep,2020

3. Beyond ALK‐RET, ROS1 and other oncogene fusions in lung cancer;Kohno T;Transl Lung Cancer Res,2015

4. Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer

5. Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non–Small-Cell Lung Cancer Harboring ROS1 Rearrangement

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Entrectinib Response to ROS1-Fusion-Positive Non-Small-Cell Lung Cancer That Progressed on Crizotinib with Leptomeningeal Metastasis: A Case Report;Case Reports in Oncology;2023-12-12

2. Analysis of CD74 Occurrence in Oncogenic Fusion Proteins;International Journal of Molecular Sciences;2023-11-05